| Anti-infective | |||||
|---|---|---|---|---|---|
| Anti-infective / Amoebic infection | |||||
| mepacrine hydrochloride | Not approved for prescribing | ||||
| metronidazole | Joint formulary choice | ||||
| Oral suspension | |||||
| Metronidazole (Non-proprietary) | Joint formulary choice | ||||
| Infusion | |||||
| Metronidazole (Non-proprietary) | Hospital only | ||||
| Suppository | |||||
| Flagyl (Sanofi) | Joint formulary choice | ||||
| Vaginal gel | |||||
| Zidoval (Viatris UK Healthcare Ltd) | |||||
| Oral tablet | |||||
| Metronidazole (Non-proprietary) | |||||
| Flagyl (Sanofi) | |||||
| Cutaneous cream | |||||
| Rozex (Galderma (UK) Ltd) | |||||
| Cutaneous gel | |||||
| Metronidazole (Non-proprietary) | |||||
| Acea (Ferndale Pharmaceuticals Ltd) | |||||
| Anabact (Cambridge Healthcare Supplies Ltd) | |||||
| Metrogel (Galderma (UK) Ltd) | |||||
| Metrosa (Beaumont Pharma Ltd) | |||||
| Rozex (Galderma (UK) Ltd) | |||||
| Anti-infective / Bacterial infection | |||||
| amikacin | Hospital only | ||||
|
Amikacin prescribing
Amikacin should only be prescribed on advice from a microbiologist. |
|||||
| Solution for injection | |||||
| Amikacin (Non-proprietary) | Hospital only | ||||
| Amikin (Vianex S.A.) | Hospital only | ||||
| Nebuliser dispersion | |||||
| Arikayce (Insmed Ltd) | |||||
| amoxicillin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Amoxicillin (Non-proprietary) | Joint formulary choice | ||||
| Powder for solution for injection | |||||
| Amoxicillin (Non-proprietary) | Hospital only | ||||
| Oral capsule | |||||
| Amoxicillin (Non-proprietary) | |||||
| Powder for oral suspension | |||||
| Amoxicillin (Non-proprietary) | |||||
| ampicillin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Ampicillin (Non-proprietary) | Joint formulary choice | ||||
| Powder for solution for injection | |||||
| Ampicillin (Non-proprietary) | Hospital only | ||||
| Oral capsule | |||||
| Ampicillin (Non-proprietary) | |||||
| azithromycin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Azithromycin (Non-proprietary) | Joint formulary choice | ||||
| Zithromax (Pfizer Ltd) | Joint formulary choice | ||||
| Powder for solution for infusion | |||||
| Azithromycin (Non-proprietary) | |||||
| Zedbac (Aspire Pharma Ltd) | Hospital only | ||||
| Eye drops | |||||
| Azyter (Thea Pharmaceuticals Ltd) | |||||
| Oral tablet | |||||
| Azithromycin (Non-proprietary) | |||||
| Oral capsule | |||||
| Azithromycin (Non-proprietary) | |||||
| Zithromax (Pfizer Ltd) | |||||
| aztreonam | Hospital only | ||||
| Powder for solution for injection | |||||
| Azactam (Bristol-Myers Squibb Pharmaceuticals Ltd) | Hospital only | ||||
| Powder and solvent for nebuliser solution | |||||
| Cayston (Gilead Sciences Ltd) | Not approved for prescribing | ||||
| benzathine benzylpenicillin | |||||
| Powder and solvent for suspension for injection | |||||
| Benzathine benzylpenicillin (Non-proprietary) | |||||
| benzylpenicillin sodium | Hospital only | ||||
| Powder for solution for injection | |||||
| Benzylpenicillin sodium (Non-proprietary) | Hospital only | ||||
| cefaclor | Hospital only | ||||
| Modified-release tablet | |||||
| Distaclor MR (Flynn Pharma Ltd) | Hospital only | ||||
| Oral suspension | |||||
| Distaclor (Flynn Pharma Ltd) | Hospital only | ||||
| Oral capsule | |||||
| Distaclor (Flynn Pharma Ltd) | |||||
| cefadroxil | Hospital only | ||||
| Oral capsule | |||||
| Cefadroxil (Non-proprietary) | |||||
| cefalexin | Joint formulary choice | ||||
| Oral suspension | |||||
| Cefalexin (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Cefalexin (Non-proprietary) | |||||
| Oral capsule | |||||
| Cefalexin (Non-proprietary) | |||||
| cefazolin | |||||
| Powder for solution for injection | |||||
| Cefazolin (Non-proprietary) | |||||
| cefepime | |||||
| Powder for solution for injection | |||||
| Renapime (Renascience Pharma Ltd) | |||||
| cefepime with enmetazobactam | |||||
| Powder for solution for infusion | |||||
| Cefepime with enmetazobactam (Non-proprietary) | |||||
| cefiderocol | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
July 2021 - the Joint Prescribing Group (JPG) agreed to approve the addition of cefiderocol to the joint formulary for the management of anaerobic gram-negative infections. Cefiderocol may only be prescribed under the advice of a consultant microbiologist. |
|||||
| Powder for solution for infusion | |||||
| Fetcroja (Shionogi BV) | Hospital only | ||||
| cefixime | Hospital only | ||||
| Oral tablet | |||||
| Suprax (Advanz Pharma) | |||||
| cefotaxime | Hospital only | ||||
| Powder for solution for injection | |||||
| Cefotaxime (Non-proprietary) | Hospital only | ||||
| cefoxitin | |||||
| Powder for solution for injection | |||||
| Cefoxitin (Non-proprietary) | |||||
| Renoxitin (Renascience Pharma Ltd) | |||||
| cefradine | Not approved for prescribing | ||||
| Oral capsule | |||||
| Cefradine (Non-proprietary) | |||||
| ceftaroline fosamil | Not approved for prescribing | ||||
| Powder for solution for infusion | |||||
| Zinforo (Pfizer Ltd) | |||||
| ceftazidime | Hospital only | ||||
| Powder for solution for injection | |||||
| Ceftazidime (Non-proprietary) | Hospital only | ||||
| Fortum (Sandoz Ltd) | Hospital only | ||||
| ceftazidime with avibactam | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
November 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of ceftazidime/avibactam to the joint formulary. Ceftazidime/avibactam may only be prescribed under the advice of a consultant microbiologist. |
|||||
| Powder for solution for infusion | |||||
| Zavicefta (Pfizer Ltd) | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
November 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of ceftazidime/avibactam to the joint formulary. Ceftazidime/avibactam may only be prescribed under the advice of a consultant microbiologist. |
|||||
| ceftobiprole | Not approved for prescribing | ||||
| Powder for solution for infusion | |||||
| Zevtera (Correvio UK Ltd) | |||||
| ceftolozane with tazobactam | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
November 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of ceftolozane/tazobactam to the joint formulary. Ceftolozane/tazobactam may only be prescribed under the advice of a consultant microbiologist. |
|||||
| Powder for solution for infusion | |||||
| Zerbaxa (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
November 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of ceftolozane/tazobactam to the joint formulary. Ceftolozane/tazobactam may only be prescribed under the advice of a consultant microbiologist. |
|||||
| ceftriaxone | Hospital only | ||||
| Powder for solution for injection | |||||
| Ceftriaxone (Non-proprietary) | Hospital only | ||||
| Rocephin (Roche Products Ltd) | Hospital only | ||||
| cefuroxime | Hospital only | ||||
| Oral suspension | |||||
| Zinnat (Sandoz Ltd) | Not approved for prescribing | ||||
| Powder for solution for injection | |||||
| Cefuroxime (Non-proprietary) | |||||
| Aprokam (Thea Pharmaceuticals Ltd) | |||||
| Ximaract (Bausch & Lomb UK Ltd) | |||||
| Zinacef (Sandoz Ltd) | |||||
| Oral tablet | |||||
| Cefuroxime (Non-proprietary) | |||||
| Zinnat (Sandoz Ltd) | |||||
| chloramphenicol | Hospital only | ||||
| Powder for solution for injection | |||||
| Chloramphenicol (Non-proprietary) | Hospital only | ||||
| Ear drops | |||||
| Chloramphenicol (Non-proprietary) | |||||
| Eye drops | |||||
| Chloramphenicol (Non-proprietary) | |||||
| Eykappo (Aspire Pharma Ltd) | |||||
| Eye ointment | |||||
| Chloramphenicol (Non-proprietary) | |||||
| Oral capsule | |||||
| Chloramphenicol (Non-proprietary) | |||||
| ciprofloxacin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Ciproxin (Bayer Plc) | Joint formulary choice | ||||
| Infusion | |||||
| Ciprofloxacin (Non-proprietary) | Hospital only | ||||
| Solution for infusion | |||||
| Ciprofloxacin (Non-proprietary) | Hospital only | ||||
| Ear drops | |||||
| Cetraxal (Aspire Pharma Ltd) | |||||
| Eye drops | |||||
| Ciloxan (Novartis Pharmaceuticals UK Ltd) | |||||
| Oral tablet | |||||
| Ciprofloxacin (Non-proprietary) | |||||
| clarithromycin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Modified-release tablet | |||||
| Xetinin XL (Morningside Healthcare Ltd) | Joint formulary choice | ||||
| Oral suspension | |||||
| Clarithromycin (Non-proprietary) | Joint formulary choice | ||||
| Powder for solution for infusion | |||||
| Clarithromycin (Non-proprietary) | |||||
| Klaricid (Viatris UK Healthcare Ltd) | |||||
| Oral tablet | |||||
| Clarithromycin (Non-proprietary) | |||||
| clindamycin | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Solution for injection | |||||
| Clindamycin (Non-proprietary) | Hospital only | ||||
| Dalacin C (Pfizer Ltd) | Hospital only | ||||
| Cutaneous emulsion | |||||
| Dalacin T (Pfizer Ltd) | |||||
| Oral capsule | |||||
| Clindamycin (Non-proprietary) | |||||
| Dalacin C (Pfizer Ltd) | |||||
| Cutaneous gel | |||||
| Zindaclin (Canute Pharma Ltd) | |||||
| Vaginal cream | |||||
| Dalacin (Pfizer Ltd) | |||||
| co-amoxiclav | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Co-amoxiclav (Non-proprietary) | |||||
| Augmentin (GlaxoSmithKline UK Ltd) | |||||
| Augmentin-Duo (GlaxoSmithKline UK Ltd) | |||||
| Powder for solution for injection | |||||
| Co-amoxiclav (Non-proprietary) | |||||
| Oral tablet | |||||
| Co-amoxiclav (Non-proprietary) | |||||
| Augmentin (GlaxoSmithKline UK Ltd) | |||||
| co-fluampicil | Not approved for prescribing | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral capsule | |||||
| Co-fluampicil (Non-proprietary) | |||||
| co-trimoxazole | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Co-trimoxazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for infusion | |||||
| Co-trimoxazole (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Co-trimoxazole (Non-proprietary) | |||||
| colistimethate sodium | Hospital only |
NICE TA276 |
|||
| Powder for solution for injection | |||||
| Colomycin (Teva UK Ltd) | Hospital only | ||||
| Inhalation powder | |||||
| Colobreathe (Teva UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for nebuliser solution | |||||
| Colicym (Kent Pharma (UK) Ltd) | |||||
| Promixin (Zambon UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| dalbavancin | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
December 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of dalbavancin to the joint formulary. Dalbavancin may only be prescribed under the advice of a consultant microbiologist. |
|||||
| Powder for solution for infusion | |||||
| Xydalba (Correvio UK Ltd) | Hospital only | ||||
|
This drug may only be prescribed under the advice of a consultant microbiologist
December 2018 - The Joint Prescribing Group (JPG) agreed to approve the addition of dalbavancin to the joint formulary. Dalbavancin may only be prescribed under the advice of a consultant microbiologist. |
|||||
| daptomycin | Hospital only | ||||
| Powder for solution for infusion | |||||
| Daptomycin (Non-proprietary) | |||||
| Cubicin (Merck Sharp & Dohme (UK) Ltd) | |||||
| delafloxacin | |||||
| Powder for solution for infusion | |||||
| Quofenix (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Oral tablet | |||||
| Quofenix (A. Menarini Farmaceutica Internazionale SRL) | |||||
| demeclocycline hydrochloride | Not approved for prescribing | ||||
| Oral tablet | |||||
| Demeclocycline hydrochloride (Non-proprietary) | |||||
| Oral capsule | |||||
| Demeclocycline hydrochloride (Non-proprietary) | |||||
| doxycycline | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Dispersible tablet | |||||
| Vibramycin-D (Pfizer Ltd) | |||||
| Modified-release capsule | |||||
| Efracea (Galderma (UK) Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Periostat (Alliance Pharmaceuticals Ltd) | |||||
| Oral capsule | |||||
| Doxycycline (Non-proprietary) | |||||
| eravacycline | |||||
| Powder for solution for infusion | |||||
| Xerava (PAION Deutschland GmbH) | |||||
| ertapenem | Hospital only | ||||
| Powder for solution for infusion | |||||
| Ertapenem (Non-proprietary) | |||||
| Invanz (Merck Sharp & Dohme (UK) Ltd) | |||||
| erythromycin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Gastro-resistant tablet | |||||
| Erythromycin (Non-proprietary) | Joint formulary choice | ||||
| Oral suspension | |||||
| Erythromycin (Non-proprietary) | Joint formulary choice | ||||
| Powder for solution for infusion | |||||
| Erythromycin (Non-proprietary) | |||||
| Oral tablet | |||||
| Erythromycin (Non-proprietary) | |||||
| Erythrocin (Advanz Pharma) | |||||
| fidaxomicin | Specialist knowledge/initiation | ||||
|
FIDAXOMICIN
Fidaxomicin should only be prescribed on advice from a microbiologist. |
|||||
| Oral suspension | |||||
| Fidaxomicin (Non-proprietary) | |||||
| Oral tablet | |||||
| Fidaxomicin (Non-proprietary) | |||||
| flucloxacillin | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Flucloxacillin (Non-proprietary) | Joint formulary choice | ||||
| Powder for solution for injection | |||||
| Flucloxacillin (Non-proprietary) | Hospital only | ||||
| Oral capsule | |||||
| Flucloxacillin (Non-proprietary) | |||||
| fosfomycin | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
|
FOSFOMYCIN
|
|||||
| Powder for solution for infusion | |||||
| Fosfomycin (Non-proprietary) | |||||
| Fomicyt (Kent Pharma (UK) Ltd) | |||||
| Granules for oral solution | |||||
| Fosfomycin (Non-proprietary) | |||||
| Alexi (Nordic Pharma Ltd) | |||||
| Monuril (Zambon UK Ltd) | |||||
| fusidic acid | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Fucidin (LEO Pharma) | Specialist knowledge/initiation | ||||
| Modified-release drops | |||||
| Fusidic acid (Non-proprietary) | |||||
| Powder and solvent for solution for infusion | |||||
| Fusidic acid (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Fucidin (LEO Pharma) | |||||
| Cutaneous ointment | |||||
| Fucidin (LEO Pharma) | |||||
| Cutaneous cream | |||||
| Fusidic acid (Non-proprietary) | |||||
| Fucidin (LEO Pharma) | |||||
| gentamicin | Hospital only | ||||
| Solution for injection | |||||
| Gentamicin (Non-proprietary) | Hospital only | ||||
| Cidomycin (Advanz Pharma) | Hospital only | ||||
| Infusion | |||||
| Gentamicin (Non-proprietary) | Hospital only | ||||
| Ear/eye drops solution | |||||
| Gentamicin (Non-proprietary) | |||||
| imipenem with cilastatin | Hospital only | ||||
| Powder for solution for infusion | |||||
| Imipenem with cilastatin (Non-proprietary) | |||||
| imipenem with cilastatin and relebactam | |||||
| Powder for solution for infusion | |||||
| Recarbrio (Merck Sharp & Dohme (UK) Ltd) | |||||
| levofloxacin | Hospital only | ||||
| Infusion | |||||
| Levofloxacin (Non-proprietary) | Hospital only | ||||
| Solution for infusion | |||||
| Levofloxacin (Non-proprietary) | Hospital only | ||||
| Nebuliser liquid | |||||
| Quinsair (Chiesi Ltd) | |||||
| Eye drops | |||||
| Levofloxacin (Non-proprietary) | Not approved for prescribing | ||||
| Eyflox (Aspire Pharma Ltd) | |||||
| Oftaquix (Santen UK Ltd) | Not approved for prescribing | ||||
| Oxalux (Kestrel Ophthalmics Ltd) | |||||
| Oral tablet | |||||
| Levofloxacin (Non-proprietary) | |||||
| Evoxil (Kent Pharma (UK) Ltd) | |||||
| linezolid | Hospital only | ||||
| Oral suspension | |||||
| Zyvox (Pfizer Ltd) | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| Infusion | |||||
| Linezolid (Non-proprietary) | Hospital only | ||||
| Zyvox (Pfizer Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Linezolid (Non-proprietary) | |||||
| Zyvox (Pfizer Ltd) | |||||
| lymecycline | |||||
| Oral capsule | |||||
| Lymecycline (Non-proprietary) | |||||
| Tetralysal (Galderma (UK) Ltd) | |||||
| meropenem | Hospital only | ||||
| Powder for solution for injection | |||||
| Meropenem (Non-proprietary) | Hospital only | ||||
| Meronem (Pfizer Ltd) | Hospital only | ||||
| meropenem with vaborbactam | |||||
| Powder for solution for infusion | |||||
| Vaborem (A. Menarini Farmaceutica Internazionale SRL) | |||||
| metronidazole | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Metronidazole (Non-proprietary) | Joint formulary choice | ||||
| Infusion | |||||
| Metronidazole (Non-proprietary) | Hospital only | ||||
| Suppository | |||||
| Flagyl (Sanofi) | Joint formulary choice | ||||
| Vaginal gel | |||||
| Zidoval (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
| Oral tablet | |||||
| Metronidazole (Non-proprietary) | |||||
| Flagyl (Sanofi) | |||||
| Cutaneous cream | |||||
| Rozex (Galderma (UK) Ltd) | |||||
| Cutaneous gel | |||||
| Metronidazole (Non-proprietary) | |||||
| Acea (Ferndale Pharmaceuticals Ltd) | |||||
| Anabact (Cambridge Healthcare Supplies Ltd) | |||||
| Metrogel (Galderma (UK) Ltd) | |||||
| Metrosa (Beaumont Pharma Ltd) | |||||
| Rozex (Galderma (UK) Ltd) | |||||
| minocycline | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Acnamino MR (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Minocin MR (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Minocycline (Non-proprietary) | |||||
| moxifloxacin | Hospital only | ||||
| Infusion | |||||
| Moxifloxacin (Non-proprietary) | Hospital only | ||||
| Solution for infusion | |||||
| Moxifloxacin (Non-proprietary) | |||||
| Eye drops | |||||
| Moxifloxacin (Non-proprietary) | |||||
| Moxivig (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Moxifloxacin (Non-proprietary) | |||||
| neomycin sulfate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral solution | |||||
| Neomycin sulfate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ofloxacin | Specialist knowledge/initiation | ||||
| Eye drops | |||||
| Exocin (AbbVie Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Ofloxacin (Non-proprietary) | |||||
| oritavancin | |||||
| Powder for solution for infusion | |||||
| Tenkasi (A. Menarini Farmaceutica Internazionale SRL) | |||||
| oxytetracycline | Joint formulary choice | ||||
| Oral tablet | |||||
| Oxytetracycline (Non-proprietary) | |||||
| phenoxymethylpenicillin | Joint formulary choice | ||||
| Oral solution | |||||
| Phenoxymethylpenicillin (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Phenoxymethylpenicillin (Non-proprietary) | |||||
| piperacillin with tazobactam | Hospital only | ||||
| Powder for solution for infusion | |||||
| Piperacillin with tazobactam (Non-proprietary) | |||||
| Tazocin (Pfizer Ltd) | |||||
| pivmecillinam hydrochloride | Joint formulary choice | ||||
| Oral tablet | |||||
| Pivmecillinam hydrochloride (Non-proprietary) | |||||
| Selexid (Karo Healthcare UK Ltd) | |||||
| rifabutin | Hospital only | ||||
| Oral capsule | |||||
| Mycobutin (Pfizer Ltd) | |||||
| rifampicin | |||||
| Oral suspension | |||||
| Rifadin (Sanofi) | |||||
| Powder and solvent for solution for injection | |||||
| Rifampicin (Non-proprietary) | |||||
| Powder and solvent for solution for infusion | |||||
| Rifadin (Sanofi) | |||||
| Oral capsule | |||||
| Rifampicin (Non-proprietary) | |||||
| Rifadin (Sanofi) | |||||
| Rimactane (Sandoz Ltd) | |||||
| rifaximin | Not approved for prescribing |
NICE TA337 |
|||
|
Rifaximin not approved for 'small intestinal bacterial overgrowth'
September 2020 - the Joint Prescribing Group (JPG) declined the application for rifaximin to be used for small intestinal bacterial overgrowth. Formulary status - Red (not approved for prescribing) |
|||||
| Oral suspension | |||||
| Rifaximin (Non-proprietary) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Targaxan (Norgine Pharmaceuticals Ltd) | |||||
| Xifaxanta (Norgine Pharmaceuticals Ltd) | |||||
| streptomycin | Hospital only | ||||
| sulfadiazine | Hospital only | ||||
| Oral tablet | |||||
| Sulfadiazine (Non-proprietary) | |||||
| tedizolid | Not approved for prescribing | ||||
| Powder for solution for infusion | |||||
| Sivextro (Merck Sharp & Dohme (UK) Ltd) | |||||
| Oral tablet | |||||
| Sivextro (Merck Sharp & Dohme (UK) Ltd) | |||||
| teicoplanin | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| Powder and solvent for solution for injection | |||||
| Teicoplanin (Non-proprietary) | |||||
| Targocid (Sanofi) | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| temocillin | Hospital only | ||||
| Powder for solution for injection | |||||
| Negaban (Eumedica Pharma Ltd) | Hospital only | ||||
| tetracycline | Joint formulary choice | ||||
| Oral tablet | |||||
| Tetracycline (Non-proprietary) | |||||
| tigecycline | Hospital only | ||||
| Powder for solution for infusion | |||||
| Tigecycline (Non-proprietary) | |||||
| Tygacil (Pfizer Ltd) | |||||
| tobramycin | Hospital only |
NICE TA276 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Tobramycin (Non-proprietary) | Hospital only | ||||
| Inhalation powder | |||||
| Tobi Podhaler (Viatris UK Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Nebuliser liquid | |||||
| Tobramycin (Non-proprietary) | |||||
| Bramitob (Chiesi Ltd) | |||||
| Munuza (Aristo Pharma Ltd) | |||||
| TOBI (Viatris UK Healthcare Ltd) | |||||
| Tymbrineb (Teva UK Ltd) | |||||
| Vantobra (Pari Medical Ltd) | |||||
| trimethoprim | Joint formulary choice | ||||
| Oral suspension | |||||
| Trimethoprim (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Trimethoprim (Non-proprietary) | |||||
| vancomycin | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Powder for solution for infusion | |||||
| Vancomycin (Non-proprietary) | |||||
| Oral capsule | |||||
| Vancomycin (Non-proprietary) | |||||
| Vancocin Matrigel (Flynn Pharma Ltd) | |||||
| Anti-infective / Leprosy | |||||
| clofazimine | Hospital only | ||||
| Oral capsule | |||||
| Clofazimine (Non-proprietary) | |||||
| dapsone | Hospital only | ||||
| Oral tablet | |||||
| Dapsone (Non-proprietary) | |||||
| rifampicin | Hospital only | ||||
|
RIFAMPICIN
For the treatment of infections other than tuberculosis and leprosy, rifampicin should only be prescribed only on advice from a microbiologist. |
|||||
| Oral suspension | |||||
| Rifadin (Sanofi) | Hospital only | ||||
|
RIFAMPICIN
For the treatment of infections other than tuberculosis and leprosy, rifampicin should only be prescribed only on advice from a microbiologist. |
|||||
| Powder and solvent for solution for injection | |||||
| Rifampicin (Non-proprietary) | Hospital only | ||||
| Powder and solvent for solution for infusion | |||||
| Rifadin (Sanofi) | Hospital only | ||||
| Oral capsule | |||||
| Rifampicin (Non-proprietary) | |||||
| Rifadin (Sanofi) | |||||
| Rimactane (Sandoz Ltd) | |||||
| Anti-infective / Tuberculosis | |||||
| aminosalicylic acid | Hospital only | ||||
| Gastro-resistant granules | |||||
| Granupas (Eurocept International bv) | Hospital only | ||||
| bedaquiline | Hospital only | ||||
| Oral tablet | |||||
| Sirturo (Janssen-Cilag Ltd) | |||||
| cycloserine | Hospital only | ||||
| Oral capsule | |||||
| Cycloserine (Non-proprietary) | |||||
| delamanid | Hospital only | ||||
| Oral tablet | |||||
| Deltyba (Imported) | |||||
| ethambutol hydrochloride | Hospital only | ||||
| Oral tablet | |||||
| Ethambutol hydrochloride (Non-proprietary) | |||||
| isoniazid | Hospital only | ||||
|
Prophylaxis of tuberculosis
Hospital only PLEASE NOTE: Isoniazid is prescribed as hospital only for the TREATMENT of tuberculosis. Specialist knowledge/initiation For PROPHYLAXIS of tuberculosis ISONIAZID tablets are for SPECIALIST INITIATION and can be continued to be prescribed in primary care. |
|||||
| Solution for injection | |||||
| Isoniazid (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Isoniazid (Non-proprietary) | |||||
| pyrazinamide | Hospital only | ||||
| Oral tablet | |||||
| Pyrazinamide (Non-proprietary) | |||||
| Zinamide (Genus Pharmaceuticals Ltd) | |||||
| rifabutin | Hospital only | ||||
| Oral capsule | |||||
| Mycobutin (Pfizer Ltd) | |||||
| rifampicin | Hospital only | ||||
|
RIFAMPICIN
For the treatment of infections other than tuberculosis and leprosy, rifampicin should only be prescribed only on advice from a microbiologist. |
|||||
| Oral suspension | |||||
| Rifadin (Sanofi) | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Rifampicin (Non-proprietary) | Hospital only | ||||
| Powder and solvent for solution for infusion | |||||
| Rifadin (Sanofi) | Hospital only | ||||
| Oral capsule | |||||
| Rifampicin (Non-proprietary) | |||||
| Rifadin (Sanofi) | |||||
| Rimactane (Sandoz Ltd) | |||||
| rifampicin with ethambutol, isoniazid and pyrazinamide | Hospital only | ||||
| Oral tablet | |||||
| Voractiv (Genus Pharmaceuticals Ltd) | |||||
| rifampicin with isoniazid | Hospital only | ||||
| Oral tablet | |||||
| Rifinah (Sanofi) | |||||
| rifampicin with isoniazid and pyrazinamide | Hospital only | ||||
| Oral tablet | |||||
| Rifater (Sanofi) | |||||
| streptomycin | Hospital only | ||||
| Anti-infective / Urinary tract infections | |||||
| estradiol | |||||
| Pessary | |||||
| Estradiol (Non-proprietary) | |||||
| Vagifem (Novo Nordisk Ltd) | |||||
| Vagirux (Gedeon Richter (UK) Ltd) | |||||
| Vaginal delivery system | |||||
| Estring (Pfizer Ltd) | |||||
| Transdermal patch | |||||
| Estraderm MX (Norgine Pharmaceuticals Ltd) | |||||
| Estradot (Sandoz Ltd) | |||||
| Evorel (Theramex HQ UK Ltd) | |||||
| FemSeven (Theramex HQ UK Ltd) | |||||
| Progynova TS (Bayer Plc) | |||||
| Spray | |||||
| Lenzetto (Gedeon Richter (UK) Ltd) | |||||
| Oral tablet | |||||
| Estradiol (Non-proprietary) | |||||
| Elleste Solo (Viatris UK Healthcare Ltd) | |||||
| Progynova (Bayer Plc) | |||||
| Zumenon (Viatris UK Healthcare Ltd) | |||||
| Transdermal gel | |||||
| Oestrogel (Besins Healthcare (UK) Ltd) | |||||
| Sandrena (Orion Pharma (UK) Ltd) | |||||
| estriol | |||||
| Pessary | |||||
| Estriol (Non-proprietary) | |||||
| Imvaggis (Besins Healthcare (UK) Ltd) | |||||
| Vaginal gel | |||||
| Blissel (Consilient Health Ltd) | |||||
| Vaginal cream | |||||
| Estriol (Non-proprietary) | |||||
| methenamine hippurate | Joint formulary choice | ||||
| Oral tablet | |||||
| Methenamine hippurate (Non-proprietary) | |||||
| nitrofurantoin | Joint formulary choice | ||||
| Modified-release capsule | |||||
| Nitrofurantoin (Non-proprietary) | |||||
| Oral suspension | |||||
| Nitrofurantoin (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Nitrofurantoin (Non-proprietary) | |||||
| Oral capsule | |||||
| Nitrofurantoin (Non-proprietary) | |||||
| Anti-infective / Fungal infection | |||||
| amphotericin B | Hospital only | ||||
|
MHRA warning - fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations
There is a potential risk of fatal overdose due to confusion between lipid-based and non-lipid-based formulations of parenteral amphotericin B. These formulations are not interchangeable. When prescribing, communicating and dispensing amphotericin products, use both the complete generic name and the proprietary (brand) name.
Verify the product name and dose before administration, especially if the dose prescribed exceeds 1·5 mg/kg—the maximum recommended dose for Fungizone. |
|||||
| Powder for solution for infusion | |||||
| Fungizone (Neon Healthcare Ltd) | |||||
| Powder for dispersion for infusion | |||||
| Amphotericin B (Non-proprietary) | |||||
| AmBisome (Gilead Sciences Ltd) | |||||
| anidulafungin | Hospital only | ||||
|
ANIDULAFUNGIN
|
|||||
| Powder for solution for infusion | |||||
| Anidulafungin (Non-proprietary) | |||||
| Ecalta (Pfizer Ltd) | |||||
| caspofungin | Not approved for prescribing | ||||
| Powder for solution for infusion | |||||
| Caspofungin (Non-proprietary) | |||||
| Cancidas (Merck Sharp & Dohme (UK) Ltd) | |||||
| fluconazole | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Fluconazole (Non-proprietary) | Joint formulary choice | ||||
| Diflucan (Pfizer Ltd) | Joint formulary choice | ||||
| Solution for infusion | |||||
| Fluconazole (Non-proprietary) | Hospital only | ||||
| Oral capsule | |||||
| Fluconazole (Non-proprietary) | Joint formulary choice | ||||
| Diflucan (Pfizer Ltd) | |||||
| flucytosine | Hospital only | ||||
| griseofulvin | Joint formulary choice | ||||
| Oral tablet | |||||
| Griseofulvin (Non-proprietary) | |||||
| isavuconazole | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for infusion | |||||
| Cresemba (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral capsule | |||||
| Cresemba (Pfizer Ltd) | |||||
| itraconazole | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Itraconazole (Non-proprietary) | Joint formulary choice | ||||
| Sporanox (Janssen-Cilag Ltd) | Joint formulary choice | ||||
| Solution for infusion | |||||
| Itraconazole (Non-proprietary) | |||||
| Oral capsule | |||||
| Itraconazole (Non-proprietary) | |||||
| micafungin | Hospital only | ||||
|
MICAFUNGIN
Microbiology Approval required |
|||||
| Powder for solution for infusion | |||||
| Micafungin (Non-proprietary) | |||||
| Mycamine (Astellas Pharma Ltd) | |||||
| nystatin | |||||
| Oral suspension | |||||
| Nystatin (Non-proprietary) | |||||
| posaconazole | Hospital only | ||||
| Gastro-resistant tablet | |||||
| Posaconazole (Non-proprietary) | |||||
| Noxafil (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
| Oral suspension | |||||
| Posaconazole (Non-proprietary) | |||||
| Noxafil (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Noxafil (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
| rezafungin | |||||
| Powder for solution for infusion | |||||
| Rezafungin (Non-proprietary) | |||||
| voriconazole | Shared care guideline | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| VFEND (Pfizer Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Powder for solution for infusion | |||||
| Voriconazole (Non-proprietary) | |||||
| VFEND (Pfizer Ltd) | |||||
| Oral tablet | |||||
| Voriconazole (Non-proprietary) | |||||
| VFEND (Pfizer Ltd) | |||||
| Anti-infective / Pneumocystis pneumonia | |||||
| atovaquone | Hospital only | ||||
| Oral suspension | |||||
| Atovaquone (Non-proprietary) | |||||
| Wellvone (GlaxoSmithKline UK Ltd) | Hospital only | ||||
| co-trimoxazole | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Co-trimoxazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for infusion | |||||
| Co-trimoxazole (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Co-trimoxazole (Non-proprietary) | |||||
| dapsone | Hospital only | ||||
| Oral tablet | |||||
| Dapsone (Non-proprietary) | |||||
| pentamidine isetionate | Hospital only | ||||
| Powder for solution for injection | |||||
| Pentamidine isetionate (Non-proprietary) | |||||
| Pentacarinat (Sanofi) | Hospital only | ||||
| Anti-infective / Helminth infection | |||||
| albendazole | Hospital only | ||||
| Chewable tablet | |||||
| Albendazole (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Albendazole (Non-proprietary) | |||||
| diethylcarbamazine | Not approved for prescribing | ||||
| ivermectin | Hospital only | ||||
|
Ivermectin cream for the treatment of papulopustular rosacea
May 2019 - The Joint Prescribing Group (JPG) agreed to approve the addition of Ivermectin (Soolantra®) cream to the joint formulary for the treatment of papulopustular rosacea. |
|||||
| Oral tablet | |||||
| Ivermectin (Non-proprietary) | |||||
| Cutaneous cream | |||||
| Soolantra (Galderma (UK) Ltd) | |||||
| levamisole | Not approved for prescribing | ||||
| Oral tablet | |||||
| Ergamisol (Imported (Belgium)) | |||||
| mebendazole | Joint formulary choice | ||||
| Chewable tablet | |||||
| Vermox (Janssen-Cilag Ltd) | Joint formulary choice | ||||
| Oral suspension | |||||
| Vermox (Janssen-Cilag Ltd) | Joint formulary choice | ||||
| praziquantel | Hospital only | ||||
| Oral tablet | |||||
| Praziquantel (Non-proprietary) | |||||
| Anti-infective / Coronavirus | |||||
| molnupiravir | |||||
| Oral capsule | |||||
| Lagevrio (Merck Sharp & Dohme (UK) Ltd) | |||||
| nirmatrelvir with ritonavir | Hospital only |
NICE TA878 |
|||
|
Nirmatrelvir plus ritonavir (Paxlovid) for COVID-19
Paxlovid should only be prescribed by the COVID-19 Medicines Delivery Unit (CMDU), GPs should not prescribe this treatment outside of the CMDU setting. |
|||||
| Form unstated | |||||
| Paxlovid (Pfizer Ltd) | Hospital only | ||||
|
Nirmatrelvir plus ritonavir (Paxlovid) for COVID-19
Paxlovid should only be prescribed by the COVID-19 Medicines Delivery Unit (CMDU), GPs should not prescribe this treatment outside of the CMDU setting. |
|||||
| remdesivir |
NICE TA971 |
||||
| Powder for solution for infusion | |||||
| Veklury (Gilead Sciences Ltd) | |||||
| sotrovimab |
NICE TA878 |
||||
| Solution for infusion | |||||
| Xevudy (GlaxoSmithKline UK Ltd) | |||||
| tocilizumab |
NICE TA375 NICE TA247 NICE TA518 NICE TA878 |
||||
| Solution for injection | |||||
| RoActemra (Roche Products Ltd) | |||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| Solution for infusion | |||||
| RoActemra (Roche Products Ltd) | |||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| Anti-infective / HIV infection | |||||
| abacavir | Hospital only | ||||
| Oral solution | |||||
| Ziagen (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Abacavir (Non-proprietary) | |||||
| Ziagen (ViiV Healthcare UK Ltd) | |||||
| abacavir with dolutegravir and lamivudine | Hospital only | ||||
| Oral tablet | |||||
| Triumeq (ViiV Healthcare UK Ltd) | |||||
| abacavir with lamivudine | Hospital only | ||||
| Oral tablet | |||||
| Abacavir with lamivudine (Non-proprietary) | |||||
| Kivexa (ViiV Healthcare UK Ltd) | |||||
| abacavir with lamivudine and zidovudine | Hospital only | ||||
| atazanavir | Hospital only | ||||
| Oral capsule | |||||
| Atazanavir (Non-proprietary) | |||||
| atazanavir with cobicistat | Hospital only | ||||
| Oral tablet | |||||
| Evotaz (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
| bictegravir with emtricitabine and tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Bictegravir with emtricitabine and tenofovir alafenamide (Non-proprietary) | |||||
| Biktarvy (Gilead Sciences Ltd) | |||||
| cabotegravir | Hospital only |
NICE TA757 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Prolonged-release suspension for injection | |||||
| Vocabria (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Vocabria (ViiV Healthcare UK Ltd) | |||||
| cobicistat | Hospital only | ||||
| Oral tablet | |||||
| Tybost (Gilead Sciences Ltd) | |||||
| darunavir | Hospital only | ||||
| Oral suspension | |||||
| Prezista (Janssen-Cilag Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Darunavir (Non-proprietary) | |||||
| Prezista (Janssen-Cilag Ltd) | |||||
| darunavir with cobicistat | Hospital only | ||||
| Oral tablet | |||||
| Rezolsta (Janssen-Cilag Ltd) | |||||
| darunavir with cobicistat, emtricitabine and tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Symtuza (Janssen-Cilag Ltd) | |||||
| dolutegravir | Hospital only | ||||
| Dispersible tablet | |||||
| Tivicay (ViiV Healthcare UK Ltd) | |||||
| Oral tablet | |||||
| Tivicay (ViiV Healthcare UK Ltd) | |||||
| dolutegravir with rilpivirine | Hospital only | ||||
| Oral tablet | |||||
| Juluca (ViiV Healthcare UK Ltd) | |||||
| doravirine | |||||
| Oral tablet | |||||
| Pifeltro (Merck Sharp & Dohme (UK) Ltd) | |||||
| efavirenz | Hospital only | ||||
| Oral tablet | |||||
| Efavirenz (Non-proprietary) | |||||
| efavirenz with emtricitabine and tenofovir disoproxil | Hospital only | ||||
| Oral tablet | |||||
| Efavirenz with emtricitabine and tenofovir disoproxil (Non-proprietary) | |||||
| elvitegravir | Hospital only | ||||
| elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Genvoya (Gilead Sciences Ltd) | |||||
| elvitegravir with cobicistat, emtricitabine and tenofovir disoproxil | Hospital only | ||||
| Oral tablet | |||||
| Stribild (Gilead Sciences Ltd) | |||||
| emtricitabine | Hospital only | ||||
| Oral solution | |||||
| Emtriva (Gilead Sciences Ltd) | Hospital only | ||||
| Oral capsule | |||||
| Emtriva (Gilead Sciences Ltd) | |||||
| emtricitabine with rilpivirine and tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Odefsey (Gilead Sciences Ltd) | |||||
| emtricitabine with rilpivirine and tenofovir disoproxil | Hospital only | ||||
| Oral tablet | |||||
| Eviplera (Gilead Sciences Ltd) | |||||
| emtricitabine with tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Descovy (Gilead Sciences Ltd) | |||||
| emtricitabine with tenofovir disoproxil | Hospital only | ||||
| Oral tablet | |||||
| Emtricitabine with tenofovir disoproxil (Non-proprietary) | |||||
| Truvada (Gilead Sciences Ltd) | |||||
| enfuvirtide | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Fuzeon (Roche Products Ltd) | Hospital only | ||||
| etravirine | Hospital only | ||||
| Oral tablet | |||||
| Intelence (Janssen-Cilag Ltd) | |||||
| fosamprenavir | Hospital only | ||||
| fostemsavir | |||||
| Modified-release tablet | |||||
| Rukobia (ViiV Healthcare UK Ltd) | |||||
| lamivudine | Hospital only | ||||
| Oral solution | |||||
| Epivir (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Lamivudine (Non-proprietary) | |||||
| Epivir (ViiV Healthcare UK Ltd) | |||||
| Zeffix (GlaxoSmithKline UK Ltd) | |||||
| lamivudine with dolutegravir | |||||
| Oral tablet | |||||
| Dovato (ViiV Healthcare UK Ltd) | |||||
| lamivudine with tenofovir disoproxil and doravirine | |||||
| Oral tablet | |||||
| Delstrigo (Merck Sharp & Dohme (UK) Ltd) | |||||
| lopinavir with ritonavir | Hospital only | ||||
| Oral solution | |||||
| Kaletra (AbbVie Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Lopinavir with ritonavir (Non-proprietary) | |||||
| Kaletra (AbbVie Ltd) | |||||
| maraviroc | Hospital only | ||||
| Oral tablet | |||||
| Celsentri (ViiV Healthcare UK Ltd) | |||||
| nevirapine | Hospital only | ||||
| Modified-release tablet | |||||
| Nevirapine (Non-proprietary) | Hospital only | ||||
| Oral suspension | |||||
| Viramune (Boehringer Ingelheim Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Nevirapine (Non-proprietary) | |||||
| raltegravir | Hospital only | ||||
| Oral tablet | |||||
| Isentress (Merck Sharp & Dohme (UK) Ltd) | |||||
| rilpivirine | Hospital only |
NICE TA757 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Prolonged-release suspension for injection | |||||
| Rekambys (ViiV Healthcare UK Ltd) | |||||
| Oral tablet | |||||
| Edurant (Janssen-Cilag Ltd) | |||||
| ritonavir | Hospital only | ||||
| Oral tablet | |||||
| Ritonavir (Non-proprietary) | |||||
| Norvir (AbbVie Ltd) | |||||
| tenofovir disoproxil | Hospital only |
NICE TA173 |
|||
| Oral tablet | |||||
| Tenofovir disoproxil (Non-proprietary) | |||||
| Viread (Gilead Sciences Ltd) | |||||
| Oral granules | |||||
| Viread (Gilead Sciences Ltd) | |||||
| zidovudine | Hospital only | ||||
| Oral solution | |||||
| Retrovir (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Retrovir (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Oral capsule | |||||
| Zidovudine (Non-proprietary) | |||||
| Retrovir (ViiV Healthcare UK Ltd) | |||||
| zidovudine with lamivudine | Hospital only | ||||
| Oral tablet | |||||
| Zidovudine with lamivudine (Non-proprietary) | |||||
| Combivir (ViiV Healthcare UK Ltd) | |||||
| Anti-infective / Respiratory syncytial virus | |||||
| palivizumab | Hospital only | ||||
| Solution for injection | |||||
| Synagis (AstraZeneca UK Ltd) | Hospital only | ||||
| ribavirin | Hospital only |
NICE TA200 NICE TA300 |
|||
| Oral tablet | |||||
| Ribavirin (Non-proprietary) | |||||
| Oral capsule | |||||
| Ribavirin (Non-proprietary) | |||||
| Anti-infective / Influenza | |||||
| amantadine hydrochloride | Not approved for prescribing |
NICE TA158 NICE TA168 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Oral solution | |||||
| Amantadine hydrochloride (Non-proprietary) | Not approved for prescribing | ||||
| Oral capsule | |||||
| Amantadine hydrochloride (Non-proprietary) | |||||
| baloxavir marboxil | Not approved for prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Oral tablet | |||||
| Xofluza (Roche Products Ltd) | |||||
| oseltamivir | Joint formulary choice |
NICE TA158 NICE TA168 |
|||
|
NICE does not recommend this medicine for the following indications
TA158 Oseltamivir or zanamivir are not recommended for seasonal prophylaxis against influenza. |
|||||
| Oral suspension | |||||
| Tamiflu (Roche Products Ltd) | Joint formulary choice | ||||
|
NICE does not recommend this medicine for the following indications
TA158 Oseltamivir or zanamivir are not recommended for seasonal prophylaxis against influenza. |
|||||
| Oral capsule | |||||
| Oseltamivir (Non-proprietary) | |||||
| Ebilfumin (Teva UK Ltd) | |||||
| Tamiflu (Roche Products Ltd) | |||||
| zanamivir | Joint formulary choice |
NICE TA158 NICE TA168 |
|||
|
NICE does not recommend this medicine for the following indications
TA158 Oseltamivir or zanamivir are not recommended for seasonal prophylaxis against influenza. |
|||||
| Solution for infusion | |||||
| Dectova (GlaxoSmithKline UK Ltd) | |||||
| Inhalation powder | |||||
| Relenza (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
|
NICE does not recommend this medicine for the following indications
TA158 Oseltamivir or zanamivir are not recommended for seasonal prophylaxis against influenza. |
|||||
| Anti-infective / Herpesvirus infections | |||||
| aciclovir | Joint formulary choice | ||||
| Dispersible tablet | |||||
| Aciclovir (Non-proprietary) | |||||
| Zovirax (GlaxoSmithKline UK Ltd) | |||||
| Oral suspension | |||||
| Aciclovir (Non-proprietary) | Joint formulary choice | ||||
| Zovirax (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
| Solution for infusion | |||||
| Aciclovir (Non-proprietary) | Hospital only | ||||
| Powder for solution for infusion | |||||
| Aciclovir (Non-proprietary) | Hospital only | ||||
| Zovirax I.V. (GlaxoSmithKline UK Ltd) | Hospital only | ||||
| Eye ointment | |||||
| Aciclovir (Non-proprietary) | |||||
| Oral tablet | |||||
| Aciclovir (Non-proprietary) | |||||
| Cutaneous cream | |||||
| Aciclovir (Non-proprietary) | |||||
| Zovirax (GlaxoSmithKline UK Ltd, Haleon UK Ltd) | |||||
| famciclovir | Not approved for prescribing | ||||
| Oral tablet | |||||
| Famciclovir (Non-proprietary) | |||||
| Famvir (Phoenix Labs Ltd) | |||||
| inosine pranobex | Hospital only | ||||
|
Joint Prescribing Group decision
April 2019 - The Joint Prescribing Group (JPG) agreed to approve the addition of inosine pranobex to the joint formulary. Inosine pranobex may only be prescribed by or under the direction of Dr Sashidharan. Inosine pranobex may only be prescribed for recalcitrant anogenital warts after failure/intolerance/contraindication to other standard treatments. Formulary status - Blue (hospital only) |
|||||
| Oral tablet | |||||
| Imunovir (Kora Healthcare) | |||||
| valaciclovir | Hospital only | ||||
|
VALACICLOVIR
Valaciclovir should only be prescribed on advice from a virologist. |
|||||
| Oral tablet | |||||
| Valaciclovir (Non-proprietary) | |||||
| Valtrex (GlaxoSmithKline UK Ltd) | |||||
| Anti-infective / Cytomegalovirus infections | |||||
| cidofovir | |||||
| Solution for infusion | |||||
| Cidofovir (Non-proprietary) | |||||
| foscarnet sodium | Hospital only | ||||
| Solution for infusion | |||||
| Foscarnet sodium (Non-proprietary) | |||||
| Foscavir (Clinigen Healthcare Ltd) | Hospital only | ||||
| ganciclovir | Hospital only | ||||
| Powder for solution for infusion | |||||
| Ganciclovir (Non-proprietary) | |||||
| Cymevene (Neon Healthcare Ltd) | |||||
| Eye gel | |||||
| Virgan (Thea Pharmaceuticals Ltd) | |||||
| letermovir | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA591 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral tablet | |||||
| Prevymis (Merck Sharp & Dohme (UK) Ltd) | |||||
| maribavir | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA860 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral tablet | |||||
| Livtencity (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| valganciclovir | Hospital only | ||||
| Oral solution | |||||
| Valcyte (Neon Healthcare Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Valganciclovir (Non-proprietary) | |||||
| Valcyte (Neon Healthcare Ltd) | |||||
| Anti-infective / Chronic hepatitis B | |||||
| adefovir dipivoxil | Hospital only | ||||
|
ADEFOVIR DIPIVOXIL
The shared care guideline (SCG) for hepatitis B was withdrawn in January 2014. |
|||||
| entecavir | Hospital only |
NICE TA153 |
|||
| Oral solution | |||||
| Baraclude (Bristol-Myers Squibb Pharmaceuticals Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Entecavir (Non-proprietary) | |||||
| Baraclude (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
| lamivudine | Hospital only | ||||
| Oral solution | |||||
| Epivir (ViiV Healthcare UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Lamivudine (Non-proprietary) | |||||
| Epivir (ViiV Healthcare UK Ltd) | |||||
| Zeffix (GlaxoSmithKline UK Ltd) | |||||
| peginterferon alfa | Hospital only |
NICE TA200 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Pegasys (Aspire Pharma Ltd) | Hospital only | ||||
| tenofovir alafenamide | Hospital only | ||||
| Oral tablet | |||||
| Vemlidy (Gilead Sciences Ltd) | |||||
| tenofovir disoproxil | Hospital only |
NICE TA173 |
|||
| Oral tablet | |||||
| Tenofovir disoproxil (Non-proprietary) | |||||
| Viread (Gilead Sciences Ltd) | |||||
| Oral granules | |||||
| Viread (Gilead Sciences Ltd) | |||||
| Anti-infective / Chronic hepatitis C | |||||
| elbasvir with grazoprevir | Hospital only |
NICE TA413 |
|||
| Oral tablet | |||||
| Zepatier (Merck Sharp & Dohme (UK) Ltd) | |||||
| glecaprevir with pibrentasvir | Hospital only |
NICE TA499 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Oral tablet | |||||
| Glecaprevir with pibrentasvir (Non-proprietary) | |||||
| ledipasvir with sofosbuvir | Hospital only |
NICE TA363 |
|||
| Oral tablet | |||||
| Harvoni (Gilead Sciences Ltd) | |||||
| Oral granules | |||||
| Harvoni (Gilead Sciences Ltd) | |||||
| peginterferon alfa | Hospital only |
NICE TA200 |
|||
| Solution for injection | |||||
| Pegasys (Aspire Pharma Ltd) | Hospital only | ||||
| ribavirin | Hospital only |
NICE TA200 NICE TA300 |
|||
| Oral tablet | |||||
| Ribavirin (Non-proprietary) | |||||
| Oral capsule | |||||
| Ribavirin (Non-proprietary) | |||||
| sofosbuvir | Hospital only |
NICE TA330 NICE TA330 |
|||
| Oral tablet | |||||
| Sovaldi (Gilead Sciences Ltd) | |||||
| Oral granules | |||||
| Sovaldi (Gilead Sciences Ltd) | |||||
| sofosbuvir with velpatasvir | Hospital only |
NICE TA430 |
|||
| Oral tablet | |||||
| Epclusa (Gilead Sciences Ltd) | |||||
| Oral granules | |||||
| Epclusa (Gilead Sciences Ltd) | |||||
| sofosbuvir with velpatasvir and voxilaprevir | Hospital only |
NICE TA507 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Oral tablet | |||||
| Vosevi (Gilead Sciences Ltd) | |||||
| Anti-infective / Chronic hepatitis D | |||||
| bulevirtide | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA896 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for injection | |||||
| Hepcludex (Gilead Sciences Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Anti-infective / Leishmaniasis | |||||
| amphotericin B | Hospital only | ||||
|
MHRA warning - fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations
There is a potential risk of fatal overdose due to confusion between lipid-based and non-lipid-based formulations of parenteral amphotericin B. These formulations are not interchangeable. When prescribing, communicating and dispensing amphotericin products, use both the complete generic name and the proprietary (brand) name.
Verify the product name and dose before administration, especially if the dose prescribed exceeds 1·5 mg/kg—the maximum recommended dose for Fungizone. |
|||||
| Powder for solution for infusion | |||||
| Fungizone (Neon Healthcare Ltd) | |||||
| Powder for dispersion for infusion | |||||
| Amphotericin B (Non-proprietary) | |||||
| AmBisome (Gilead Sciences Ltd) | |||||
| pentamidine isetionate | Hospital only | ||||
| Powder for solution for injection | |||||
| Pentamidine isetionate (Non-proprietary) | |||||
| Pentacarinat (Sanofi) | Hospital only | ||||
| Anti-infective / Malaria | |||||
| artemether with lumefantrine | Hospital only | ||||
| Oral tablet | |||||
| Riamet (Novartis Pharmaceuticals UK Ltd) | |||||
| atovaquone with proguanil hydrochloride | Not approved for prescribing | ||||
| Oral tablet | |||||
| Atovaquone with proguanil hydrochloride (Non-proprietary) | |||||
| Malarone (GlaxoSmithKline UK Ltd) | |||||
| chloroquine | Hospital only | ||||
|
Prescribing of chloroquine for travelling purposes
Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. |
|||||
| Oral solution | |||||
| Malarivon (Wallace Manufacturing Chemists Ltd) | Hospital only | ||||
|
Prescribing of chloroquine for travelling purposes
Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. |
|||||
| Oral tablet | |||||
| Avloclor (Alliance Pharmaceuticals Ltd) | |||||
| doxycycline | Not approved for prescribing | ||||
| Dispersible tablet | |||||
| Vibramycin-D (Pfizer Ltd) | |||||
| Modified-release capsule | |||||
| Efracea (Galderma (UK) Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Periostat (Alliance Pharmaceuticals Ltd) | |||||
| Oral capsule | |||||
| Doxycycline (Non-proprietary) | |||||
| mefloquine | Not approved for prescribing | ||||
| Oral tablet | |||||
| Lariam (Neon Healthcare Ltd) | |||||
| primaquine | Hospital only | ||||
| Oral tablet | |||||
| Primaquine (Non-proprietary) | |||||
| quinine | Hospital only | ||||
| Oral tablet | |||||
| Quinine (Non-proprietary) | |||||
| Anti-infective / Toxoplasmosis | |||||
| pyrimethamine | Hospital only | ||||
| Oral tablet | |||||
| Daraprim (GlaxoSmithKline UK Ltd) | |||||